|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/18 | |||
| A61K 38/27 | |||
| A61K 38/30 |
| (11) | Patento numeris | 2501367 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10784450.8 |
| Europos patento paraiškos padavimo data | 2010-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-01-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/006996 |
| Data | 2010-11-17 |
| (87) | Numeris | WO 2011/060922 |
| Data | 2011-05-26 |
| (30) | Numeris | Data | Šalis |
| 261859 P | 2009-11-17 | US |
| (72) |
GOPINATH, Enona, US
PARK, Susan, US
ARAKAWA, Tsutomu, US
RICHARD, Joėl, FR
FAIS, Fabio, FR
|
| (73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | Formulation for HGH and RHIGF-1 combination |
| Formulation for HGH and RHIGF-1 combination |